Merck Animal Health (known as MSD Animal Health outside of the U.S. and Canada) announced Jan. 14 the introduction of Safe-Guard AquaSol (fenbendazole oral suspension) for use in U.S. poultry operations. Safe-Guard AquaSol is indicated for the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens, as well as for the treatment and control of adult A. galli and Heterakis gallinarum in breeding chickens.
"Managing gastrointestinal health properly results in better overall performance: uniformity, productivity and profitability," Dr. Ivan Alvarado, director of Poultry Technical Services at Merck Animal Health, said. “Effective management also helps to minimize the economic impact that comes as a result of production losses, which is a priority for all of our customers.
“Safe-Guard products have a long history of proven results, and we are excited to bring a new poultry formulation to the industry — one that provides a unique uniform treatment for the entire flock and has been approved by the (Food & Drug Administration) for use in chickens,” he added.
Safe-Guard AquaSol is produced with an innovative wet-milling technology that produces a highly stable suspension that can be administered through drinking water for a short treatment period of five consecutive days. The product’s smaller particle sizes help prevent sedimentation and clogged pipes, filters or nipple drinkers, the announcement said. There is no pre-slaughter withdrawal period when used according to the product label.
Safe-Guard AquaSol is available in one-liter and 1 gal. presentations. For more information about this product, contact a Merck Animal Health sales representative.
No withdrawal period is required when used according to the label. Do not use the drug in laying hens and replacement chickens intended to become laying hens. Consult a veterinarian for assistance in the diagnosis, treatment and control of parasitism.